Hovione is winner of the 16th CPhI Pharma Awards
PRIME wins the CPhI Pharma Award
PRIME wins the CPhI Pharma Award
Hovione Macau organized the St. Martin's Day in our manufacturing facility in Macau
On Drug Delivery, November 2019
Learn more about the innovations from our scientists
10 years in Cork, 60 years in the world.
The Best For The World lists are determined based on the verified B Impact Assessments of Certified B Corporations
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
in-PharmaTechnologist, September 3, 2019
Pharmaceutical Technology, September 2, 2019